Relevance of Circulating Hybrid Cells as a Non-Invasive Biomarker for Myriad Solid Tumors
M. S. Dietz, T. L. Sutton, B. S. Walker, C. E. Gast, L. Zarour, S. K. Sengupta, J. R. Swain, J. Eng, M. Parappilly, K. Limbach, A. Sattler, E. Burlingame, Y. Chin, A. Gower, J. L. Montoya Mira, , M. H. Wong
This study identifies circulating hybrid cells (CHCs) as a novel biomarker for metastatic solid tumors, showing they outnumber CTCs and exhibit tumor-initiating properties across multiple cancer types.
bioRxiv · Mar 11, 2021 · PreprintCancer Biology